RecruitingPhase 3NCT06439082A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)Sponsor: Novartis PharmaceuticalsOrange, CA · +16 more sites
RecruitingPhase 2NCT06699849Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive CrisisSponsor: CSL BehringOakland, CA · Orange, CA · +18 more sites
RecruitingPhase 3NCT06609226A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or ThalassaemiaSponsor: Novo Nordisk A/SLos Angeles, CA · Oakland, CA · +36 more sites
RecruitingPhase 3NCT06612268A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseaseSponsor: Novo Nordisk A/SLos Angeles, CA · Madera, CA · +47 more sites
RecruitingPhase 2NCT07224360Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)Sponsor: CSL BehringOrange, CA · +8 more sites